Sort
30,917 grants matching “tumor microenvironment”
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene
$781,730Dan Mercola · University Of California-Irvine · U01 · FY2012 · CA
Reprogramming the Tumor-Immune Interface in Oral Cancer
$780,996John B Sunwoo · Stanford University · R35 · FY2020 · DE
Mechanisms of impaired T-cell mechanosensing of melanoma antigens
$780,284Cheng Zhu · Georgia Institute Of Technology · U01 · FY2017 · CA
Fibroblast Heterogeneity in Pancreatic Cancer
$780,205David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2023 · CA
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$780,174William Ramses Bishai · Johns Hopkins University · R01 · FY2020 · AI
Prostate Section
$780,135Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Signal Transduction Events and the Regulation of Cell Growth
$780,073Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2018 · CA
Fibroblast Heterogeneity in Pancreatic Cancer
$779,963David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2022 · CA
Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
$779,894Lorenzo Galluzzi · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$779,653Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
SOAT1 as a targetable dependency in Pancreatic Adenocarcinoma
$778,873David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$778,382Katerina Abigail Politi · Yale University · U01 · FY2021 · CA
Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
$778,050Hongbo Chi · St. Jude Children'S Research Hospital · U01 · FY2024 · CA
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
$777,500David J Beebe · University Of Wisconsin-Madison · UH3 · FY2023 · CA
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
$777,500David J Beebe · University Of Wisconsin-Madison · UH3 · FY2022 · CA
Mechanisms of resistance to treatment in aggressive prostate cancers
$777,497Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Molecular Analysis of Breast Cancer Metastasis to the Brain
$777,064Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Preclinical toxicology and pharmacology evaluation of a newTNFR2 antagonistic monoclonal antibody for CTCL therapy
$776,973Kenneth Olivier · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2024 · CA
Pancreatic Cancer Detection Consortium
$776,970Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2024 · CA
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
$776,961Andrew Sikora · Baylor College Of Medicine · U01 · FY2019 · DE
Development of Drugs Acting at Adenosine Receptors
$775,838Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Harnessing the power of exosomes for non-coding RNA delivery
$775,509Anil K Sood · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · CA
Engineering personalized micro-tumor ecosystems
$775,492Shiladitya Sengupta · Brigham And Women'S Hospital · U01 · FY2019 · CA
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
$775,417David J Beebe · University Of Wisconsin-Madison · UG3 · FY2020 · CA
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$775,192Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA